 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | bioMerieux |
| Street 1: | 100 Rodolphe St |
| Street 2: | |
| City: | Durham |
| Province: | NC |
| Post Code: | 27712 |
| Country: | United States of America |
| Phone: | 800-682-2666 |
| Organization Email: | matthew.mikell@biomerieux.com |
| Web Site: | http://www.biomerieux-usa.com |
| Other Online Presence: | http://www.biomerieux.com |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | 1450405 |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Company |
| Organization Description: | |
| For 60 years, bioMérieux has bee a world leader in the field of in vitro diagnostics. We develop and produce diagnostic solutions that help healthcare professionals quickly and reliably determine a pathology or the source of a contamination and provide them with crucial information for optimal patient care.??This includes TB. We have introduced new tests globally for LTBI and plan to have FDA clearance in the USA by 2023. We'll be offering marketing and education to hospitals, clinics and citizens. |
|
| Do you know about the UNHLM declaration: | Yes |
Specializations / Areas of Work | |
|
Provision of drugs, diagnostics and commodities Research and Development Working on Key Populations related to TB |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 6 - 10 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 1 - 5 |
| How did you hear about the Stop TB Partnership: | Internet search |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Network with other partners |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Our Global projects in the field of tuberculosis: APRECIT: Evaluation of strategies to improve the screening and overall management of latent tuberculosis infection in Cameroon and Madagascar. DEDICATE: Evaluation of the clinical performance of two innovative blood tests for the triage and diagnosis of pediatric and extra-pulmonary forms of tuberculosis in Bangladesh. HINTT: HBHA immune-monitoring for following-up tuberculosis treatment and improving the success rate. Labo2S: Reinforce the capacities of laboratories in charge of the diagnosis and biological monitoring of patients infected with HIV and/or tuberculosis in Niger. |
|
Geographical Reach | |
| Which country is your headquarters located in: | France |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
United States of America |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
Laboratory Strengthening: Strengthening diagnosis: We work with partners to help them develop an efficient laboratory system that will provide universal access to quality health services for vulnerable populations. Height biosafety level-3 (BSL-3) laboratories have been built in partnership with NTPs in Bangladesh, Brazil, China, Haiti, Laos, Lebanon, Mali and Tajikistan to improve a global technical expertise, surveillance and epidemiology. We also provide technical training on TB diagnostics, technology transfer, equipment and supplies of reagents and consumables, quality data management, and biobanking. New Diagnostics: Capacity building: Technology transfer programs are key to improving the diagnosis of childhood TB and developing tools for the evaluation and monitoring of treatment. We support LMIC research institutions and health authorities to develop these programs alongside clinical research studies, with the assistance of young researchers from the GABRIEL network. Research: Our strategy is focused on working with National TB control Programs (NTPs) in LMICs, alongside local institutions involved in the diagnosis and research of TB. This includes members of the GABRIEL network and the Institut Pasteur’s international network, field experts such as doctors, paediatricians and community health workers, as well as stakeholders and key opinion leaders worldwide. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | July 1, 2022 |
| Last updated: | July 1, 2022 |